Aquilo Capital Management, LLC Amryt Pharma PLC Transaction History

Aquilo Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$6.68 - $7.58 $668,000 - $758,000	100,000 Added 5.0%	2,098,993 $15.3 Million
Q3 2022 Nov 14, 2022	BUY	$6.8 - $8.01 $899,918 - $1.06 Million	132,341 Added 7.09%	1,998,993 $13.8 Million
Q2 2022 Aug 15, 2022	BUY	$6.85 - $8.87 $1.55 Million - $2.01 Million	226,652 Added 13.82%	1,866,652 $13 Million
Q4 2021 Feb 14, 2022	BUY	$9.44 - $12.24 $2.36 Million - $3.06 Million	250,000 Added 17.99%	1,640,000 $17.7 Million
Q3 2021 Nov 15, 2021	BUY	$9.63 - $12.47 $2.41 Million - $3.12 Million	250,000 Added 21.93%	1,390,000 $16.7 Million
Q2 2021 Aug 16, 2021	BUY	$10.9 - $14.29 $3.71 Million - $4.86 Million	340,000 Added 42.5%	1,140,000 $13.8 Million
Q4 2020 Feb 16, 2021	BUY	$12.22 - $14.16 $9.78 Million - $11.3 Million	800,000 New	800,000 $11.3 Million

142K

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aquilo Capital Management, LLC with notifications on news.